Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Study of LY3039478 in Combination With Other Anticancer Agents in Patients With Advanced or Metastatic Solid Tumors

NCT02784795 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT02784795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02784795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Study of LY3039478 in Combination With Other Anticancer Agents in Patients With Advanced or Metastatic Solid Tumors
Lead sponsor
Eli Lilly and Company
Phase
Phase 1
Overall status
Terminated
Start date
November 4, 2016
Completion date
February 13, 2020
Enrollment
94 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, cholangiocarcinoma, colon cancer, soft tissue sarcoma, solid tumor